These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10629634)

  • 1. "Multi-enzyme-targeted" immunochemotherapy: a salvage therapy protocol.
    Klein HO; Demir G
    Anticancer Res; 1999; 19(4C):3451-8. PubMed ID: 10629634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
    Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
    J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future perspectives in advanced bladder cancer: is there a new standard?
    von der Maase H
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature.
    Zustovich F; Cartei G; Dal Bianco M; De Zorzi L; Ceravolo R; Zovato S; Salmaso F; Binato S; Artioli G; Cingarlini S; Pastorelli D
    Ann Oncol; 2006 May; 17 Suppl 5():v133-6. PubMed ID: 16807442
    [No Abstract]   [Full Text] [Related]  

  • 5. Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.
    Pagliaro LC; Millikan RE; Tu SM; Williams D; Daliani D; Papandreou CN; Logothetis CJ
    J Clin Oncol; 2002 Jul; 20(13):2965-70. PubMed ID: 12089226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma.
    Ryan CW; Vogelzang NJ; Stadler WM
    Cancer; 2002 May; 94(10):2602-9. PubMed ID: 12173327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma.
    Bensmaine M el-A ; Guillot T; Bernal ET; Janot F; Sigal R; Domenge C; Wibault P; Armand JP; Cvitkovic E
    Am J Clin Oncol; 1996 Aug; 19(4):356-62. PubMed ID: 8677904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study.
    Lin CC; Hsu CH; Huang CY; Keng HY; Tsai YC; Huang KH; Cheng AL; Pu YS
    Anticancer Drugs; 2007 Apr; 18(4):487-91. PubMed ID: 17351402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer.
    Murad AM
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):26-32. PubMed ID: 14768402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined systemic therapy and radiotherapy for bladder cancer.
    Rödel C; Weiss C; Sauer R
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():29-31. PubMed ID: 18167005
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.
    Mitin T; George A; Zietman AL; Heney NM; Kaufman DS; Uzzo RG; Dreicer R; Wallace HJ; Souhami L; Dobelbower MC; Sandler HM; Shipley WU
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):67-74. PubMed ID: 26700703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.
    Park JH; Lee JL
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):247-54. PubMed ID: 25428517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z; Dimopoulos MA; Kostakopoulos A; Karayiannis A; Sofras F; Zervas A; Giannopoulos A; Dimopoulos C
    J Urol; 1997 Aug; 158(2):408-11. PubMed ID: 9224313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of recurrent mixed germ cell tumor of the ovary after treatment with vincristine, carboplatin, fluorouracil, and ifosfamide: a case report and review of the literature.
    Balat O; Kudelka AP; Edwards CL; Verschraegen C; Kavanagh JJ
    Eur J Gynaecol Oncol; 1996; 17(5):342-4. PubMed ID: 8933826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New cytostatic agents for the treatment of head and neck cancer.
    Devriendt D; Klastersky J
    Acta Otorhinolaryngol Belg; 1997; 51(2):61-8. PubMed ID: 9241369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New chemotherapy regimens for advanced bladder cancer.
    Fagbemi SO; Stadler WM
    Semin Urol Oncol; 1998 Feb; 16(1):23-9. PubMed ID: 9508079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunochemotherapy of metastatic renal cell carcinoma with interleukin 2, interferon-alpha and 5-fluorouracil].
    Hofmockel G; Theiss M; Gruss A; Langer W; Frohmüller H
    Urologe A; 1997 Jan; 36(1):45-9. PubMed ID: 9123681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
    Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
    Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer.
    Gatzemeier U; Manegold C; Eberhard W; Wilke HJ; Chomy F; Chomy P; Khayat D; Blatter J; Seeber S; Drings P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-36-S8-38. PubMed ID: 9207315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.